This has been a big week with multiple approvals by the FDA for new molecular entities along with the approval of the first digital pill and a couple of supplemental approvals.  Here is my summary of the top regulatory news stories for pharma and biotech this week: Ultragenyx announced that the FDA has approved MEPSEVII™[…]